← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

M 10b5-1 Plan

$ Value

$161

Shares

101

Price

$2

Filed

May 9

Insider

Name

Patel Sanj K

Title

CHAIRMAN & CEO

CIK

0001532218

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-08

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

96,775

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 25, 2024. | This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.03 and $27.14. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. | The option is fully vested and exercisable.

Filing Info

Accession No.

0001415889-25-012571

Form Type

4

Issuer CIK

0001730430

Patel Sanj K's History

Date Ticker Type Value
2026-04-07 KNSA M
2026-04-07 KNSA F $236K
2026-04-07 KNSA M $0
2026-04-06 KNSA M $75K
2026-04-06 KNSA $364K
2026-04-06 KNSA M $0
2026-04-01 KNSA M
2026-04-01 KNSA F $496K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $345K 2026-04-06
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07